> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Assessing NDA/BLA Information Requests
- URL: https://www.fdaweb.com/fda-assessing-nda-bla-information-requests/
- Published: 2022-10-14T12:00:00.000Z
- Updated: 2026-09-14T18:03:14.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5152975

*Federal Register* notice: FDA is announcing an opportunity for public comment on a statement of work to assess communication between FDA and sponsors through product quality information requests during NDA/BLA reviews, and to identify best practices and areas of improvement. The independent assessment is part of FDA performance commitments under the recent drug user fee reauthorization. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2022-10-14/pdf/2022-22335.pdf?ref=fdaweb.com).